Human genomics for health: Enhancing the impact of effective research. Report of the first regional meeting for the Americas. Brasília, 15–16 May 2024
Fecha
2024-11-25Número de documento
PAHO/EIH/SK/24-0007
Metadatos
Mostrar el registro completo del ítemResumen
The regional meeting on Human Genomics for Health: Enhancing the Impact of Effective Research was convened in Brasilia on 15–16 May 2024 by the Pan American Health Organization (PAHO) with the support of World health Organization (WHO) headquarters, the PAHO/WHO country office in Brazil and the Department of Science and Technology, Ministry of Health, Brazil. This consultation aimed to provide a forum for the exchange of information and ideas on human genomics for health and convened over 100 participants from a broad spectrum of disciplines who contributed their expertise across relevant fields of research, including science policy, bioethics, national genomic initiatives, cancer, rare diseases, and congenital disorders. The meeting objective was to identify, discuss, and propose concrete actions for the implementation of human genomics in practice and for conducting genomic research in Member States. During the two-day meeting, this highly diverse group of experts shared experiences and best practices in applying genomics in clinical care and public health and conducting genomic research in the Americas, highlighting both successes and obstacles encountered in their work. Detailed discussions were held on the various challenges faced in the field, on the countries’ priorities and on the opportunities for advancement of genomics. There was a strong emphasis on the potential for collaborative efforts and the enhancement of partnerships within the Region of the Americas. This final report summarizes the reflection and discussion of the issues and challenges identified during the workshop and presents the key actions and recommendations to enhance equitable and effective genomics research in the Region, outlining a path forward for the Americas. The report underscore the necessity for coordinated action at national, regional, and global levels to equitably harness the transformative potential of human genomics in clinical care and public health.
Páginas
36 p.
Colecciones
Esta leyenda debe conservarse, junto con la URL original del artículo.Attribution-NonCommercial-ShareAlike 3.0 IGO
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Silva Junior, Jarbas Barbosa da; Lima, Nísia Trindade; Haddad, Ana Estela; Gross Galiano, Socorro; Garcia Saiso, Sebastian; Fitzgerald, James; Teixeira, Mariana Faria; Rius Sanjuan, Judit; Jimenez McInnis, Luis; D’Agostino, Marcelo (2024)[ABSTRACT]. The G20, representing the world’s largest economies, plays a critical role in shaping global health policies, initiatives and innovative solutions. As these nations navigate the complexities of digital ...
-
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (PAHOUnited StatesWashington, D.C., 2022)This workshop discussed “The Response to HTLV in the Framework of Maternal and Child Health” in the Americas. HTLV-1 impact is broad and significant, however, there are effective interventions to prevent transmission, ...
-
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (PAHOUnited StatesWashington, D.C., 2022)Human T cell lymphotropic virus (HTLV) infection affects mainly vulnerable population groups: people living in poverty in areas with very low human development indexes, sex workers, men who have sex with men, people who ...